UNIGENE LABORATORIES INC
company.status.inactiveCIK 352747fmd_01CD90MMF4K839SDP6B51CG2QKManufacturing · Medicinal Chemicals & Botanical ProductsTemplate: Standard
Coverage: Jan 01, 2009 to Mar 31, 2013, 13 periods
| Line item | FY2009 | FY2010 | FY2011 | FY2012 |
|---|---|---|---|---|
| Total revenues | 13 | 11 | 21 | 9 |
| Cost of revenue | 2 | 3 | 2 | 2 |
| Gross profit | 11 | 9 | 19 | 8 |
| Realized investment gains (losses) | – | – | – | 0 |
| Research and development | 12 | 6 | 9 | 5 |
| Selling, general and administrative | 9 | 8 | 9 | 9 |
| Total operating expenses | 25 | 22 | 24 | 19 |
| Operating income | (12) | (10) | (3) | (9) |
| Interest expense | 5 | 8 | 10 | 14 |
| Interest and investment income | 0 | 0 | 0 | 0 |
| Income before taxes | (13) | (33) | (8) | (36) |
| Income tax expense | (0) | (1) | (1) | (1) |
| Net income from continuing operations | (13) | (33) | (7) | (34) |
| Net income | (13) | (33) | (7) | (34) |